Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy

Because tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) preferentially induces apoptosis in tumor cells and plays a critical role in tumor surveillance, its receptor is an attractive target for antibody-mediated tumor therapy. Here we report that a monoclonal antibody (mAb) against t...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Kazuyoshi, Yamaguchi, Noriko, Akiba, Hisaya, Kojima, Yuko, Hayakawa, Yoshihiro, Tanner, Jane E., Sayers, Thomas J., Seki, Naoko, Okumura, Ko, Yagita, Hideo, Smyth, Mark J.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211825/
https://www.ncbi.nlm.nih.gov/pubmed/14769851
http://dx.doi.org/10.1084/jem.20031457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211825/
https://www.ncbi.nlm.nih.gov/pubmed/14769851
http://dx.doi.org/10.1084/jem.20031457

Ejemplares similares